These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1488488)

  • 21. Tardive dyskinesia and abnormal tongue movements.
    Pi EH; Simpson GM
    Br J Psychiatry; 1981 Dec; 139():526-8. PubMed ID: 7332858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
    Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH
    Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia.
    Waddington JL; Youssef HA
    Psychol Med; 1996 Jul; 26(4):681-8. PubMed ID: 8817702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed-type (limb-truncal and orofacial) bupropion-associated dyskinesia.
    Ferentinos P; Christodoulou C; Rizos E; Douzenis A; Lykouras L
    J Clin Psychopharmacol; 2010 Oct; 30(5):644-6. PubMed ID: 20841971
    [No Abstract]   [Full Text] [Related]  

  • 29. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T; Brown KW; Woods JP
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tardive dyskinesia: drug-induced damage, recognizable in dentistry at an early stage].
    Télessy I
    Fogorv Sz; 1985 Sep; 78(9):277-80. PubMed ID: 3863766
    [No Abstract]   [Full Text] [Related]  

  • 31. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK; Jankovic J
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms.
    Pantelis C; Stuart GW; Nelson HE; Robbins TW; Barnes TR
    Am J Psychiatry; 2001 Aug; 158(8):1276-85. PubMed ID: 11481163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive sequelae of tardive dyskinesia.
    DeWolfe AS; Ryan JJ; Wolf ME
    J Nerv Ment Dis; 1988 May; 176(5):270-4. PubMed ID: 2896762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
    J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients.
    Caligiuri MP; Lohr JB
    Biol Psychiatry; 1994 Jan; 35(2):104-11. PubMed ID: 7909452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Instrument measurement of lingual force variability reflects tardive tongue dyskinesia.
    Koning JP; Tenback DE; Kahn RS; Van Schelven LJ; Van Harten PN
    J Med Eng Technol; 2010 Jan; 34(1):71-7. PubMed ID: 19929569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
    Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors related to the severity of tardive dyskinesia.
    Wade JB; Hart RP; Dougherty LM
    Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 40. Accelerometric assessment of tardive dyskinesia.
    Tryon WW; Pologe B
    Am J Psychiatry; 1987 Dec; 144(12):1584-7. PubMed ID: 2891307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.